不同程度 OSAHS 患者认知功能障碍的相关性研究

注册号:

Registration number:

ChiCTR2600122329 

最近更新日期:

Date of Last Refreshed on:

2026-04-12 23:42:20 

注册时间:

Date of Registration:

2026-04-12 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

不同程度 OSAHS 患者认知功能障碍的相关性研究

Public title:

Correlation Between Severity of Obstructive Sleep Apnea-Hypopnea Syndrome and Cognitive Dysfunction

注册题目简写:

English Acronym:

研究课题的正式科学名称:

不同程度 OSAHS 患者认知功能障碍的相关性研究

Scientific title:

Correlation Between Severity of Obstructive Sleep Apnea-Hypopnea Syndrome and Cognitive Dysfunction

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

华娜 

研究负责人:

华娜;范玉净 

Applicant:

Na Hua 

Study leader:

Na Hua;Yujing Fan 

申请注册联系人电话:

Applicant telephone:

+86 13218311873

研究负责人电话:

Study leader's
telephone:

+86 13889481076

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

huanaship@163.com

研究负责人电子邮件:

Study leader's E-mail:

huanaship@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

辽宁省大连市中山区解放街6号

研究负责人通讯地址:

辽宁省大连市中山区解放街6号

Applicant address:

No. 6, Jiefang Street, Zhongshan District, Dalian City, Liaoning Province

Study leader's address:

No. 6, Jiefang Street, Zhongshan District, Dalian City, Liaoning Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

大连大学附属中山医院

Applicant's institution:

Affiliated Zhongshan Hospital of Dalian University

研究负责人所在单位:

大连大学附属中山医院

Affiliation of the Leader:

Affiliated Zhongshan Hospital of Dalian University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

PJ-KY2026-017-1

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

大连大学附属中山医院科研课题伦理审查委员会

Name of the ethic committee:

Scientific Research Ethics Review Committee of Affiliated Zhongshan Hospital of Dalian University

伦理委员会批准日期:

Date of approved by ethic committee:

2026-02-03 00:00:00

伦理委员会联系人:

徐洋

Contact Name of the ethic committee:

Yang Xu

伦理委员会联系地址:

辽宁省大连市中山区解放街6号

Contact Address of the ethic committee:

No. 6, Jiefang Street, Zhongshan District, Dalian City, Liaoning Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 411 62897702

伦理委员会联系人邮箱:

Contact email of the ethic committee:

zsyyllwyh@163.com

研究实施负责(组长)单位:

大连大学附属中山医院

Primary sponsor:

Affiliated Zhongshan Hospital of Dalian University

研究实施负责(组长)单位地址:

辽宁省大连市中山区解放街6号

Primary sponsor's address:

No. 6, Jiefang Street, Zhongshan District, Dalian City, Liaoning Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

辽宁省

市(区县):

Country:

China

Province:

Liaoning

City:

单位(医院):

大连大学附属中山医院

具体地址:

辽宁省大连市中山区解放街6号

Institution
hospital:

Affiliated Zhongshan Hospital of Dalian University

Address:

No. 6, Jiefang Street, Zhongshan District, Dalian City, Liaoning Province

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

Selected Topic (Self-Funded)

研究疾病:

阻塞性睡眠呼吸暂停低通气综合征  

Target disease:

Obstructive Sleep Apnea Hyponea Syndrome

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

1.探讨不同程度(轻、中、重)OSAHS 患者认知功能障碍、耳鸣困扰及眩晕障碍的发生率与特点。 2.分析 MoCA 评分与 THI、DHI、ESS、AHI、LSaO2、BMI、病程、睡眠结构等因素的相关性。 3.明确 OSAHS 患者认知、耳鸣、眩晕障碍的共同危险因素,探索影响 OSAHS 患者认知功能的独立预测因素,为临床多维度干预提供依据。  

Objectives of Study:

1. Explore the incidence and characteristics of cognitive dysfunction, tinnitus disturbance and vertigo disorder in patients with different degrees (mild, moderate, severe) of OSAHS. 2. Analyze the correlation between MoCA score and factors such as THI, DHI, ESS, AHI, LSaO2, BMI, disease duration, sleep structure, etc. 3. Identify the common risk factors for cognitive, tinnitus and vertigo disorders in OSAHS patients, and explore the independent predictive factors affecting the cognitive function of OSAHS patients, providing a basis for clinical multi-dimensional intervention.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 合并神经或精神疾病、脑部病变、失眠等影响认知功能评定的患者;
2. 中枢性或混合性睡眠呼吸暂停综合征;
3. 严重心、肺、肝、肾功能不全;
4. 正在服用影响睡眠和精神状态的药物或酗酒;
5. 不愿配合调查。

Exclusion criteria:

1. Comorbid neurological or psychiatric disorders, cerebral pathology, or insomnia that could interfere with cognitive assessment.
2. Central or mixed sleep apnea syndrome.
3. Severe impairment of cardiac, pulmonary, hepatic, or renal function.
4. Current use of medications affecting sleep or mental state, or alcohol abuse.
5. Unwillingness to cooperate with the study procedures.

研究实施时间:

Study execute time:

From 2026-02-01 00:00:00 To 2027-06-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-04-12 00:00:00 To 2027-06-01 00:00:00

干预措施:

Interventions:

组别:

重度OSAHS组

样本量:

50

Group:

Severe OSAHS group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

轻度OSAHS组

样本量:

50

Group:

Mild OSAHS group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

中度OSAHS组

样本量:

50

Group:

Moderate OSAHS group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

单纯打鼾组

样本量:

30

Group:

Simple snorers group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

辽宁省 

市(区县):

 

Country:

China

Province:

Liaoning

City:

单位(医院):

大连大学附属中山医院 

单位级别:

三级甲等 

Institution
hospital:

Affiliated Zhongshan Hospital of Dalian University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

耳鸣致残量表评分

指标类型:

次要指标

Outcome:

Tinnitus Handicap Inventory score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Epworth嗜睡量表评分

指标类型:

次要指标

Outcome:

Epworth Sleepiness Scale score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

眩晕残障量表评分

指标类型:

次要指标

Outcome:

Dizziness Handicap Inventory score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

多导睡眠监测

指标类型:

主要指标

Outcome:

Polysomnography

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

蒙特利尔认知评估量表评分

指标类型:

主要指标

Outcome:

Montreal Cognitive Assessment score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF;EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF;EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-04-12 23:42:14